Literature DB >> 17608530

Antineoplastic agents. 560. Isolation and structure of kitastatin 1 from an Alaskan Kitasatospora sp.

George R Pettit1, Rui Tan, Robin K Pettit, Thomas H Smith, Song Feng, Dennis L Doubek, Linda Richert, John Hamblin, Christine Weber, Jean-Charles Chapuis.   

Abstract

By utilizing a bioassay-guided separation (P388 lymphocytic leukemia and a panel of human cancer cell lines) of fermentation broths from a Kitasatospora sp. collected from a tundra soil sample taken at the shore of the Beaufort Sea, we have isolated three powerful (GI50 to 0.0006 microg/mL) cancer cell growth inhibitors (1-3) and determined their structures to be closely related cyclodepsipeptides. From 380 L fermentations of Kitasatospora sp. were obtained 2.6 mg of a new cyclodepsipeptide designated kitastatin 1 (3), accompanied by the previously known respirantin (1, 10.8 mg) and its valeryl homologue (2, 4.8 mg). The structures were determined by employment of a series of high-resolution mass and 2D NMR spectroscopic analyses. The stereochemical assignments and overall structures were confirmed by subsequent total synthesis of depsipeptide 1, as reported in the accompanying contribution.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17608530      PMCID: PMC2596607          DOI: 10.1021/np068072c

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  15 in total

1.  New cytotoxic bafilomycin C1-amide produced by Kitasatospora cheerisanensis.

Authors:  Surk-Sik Moon; Wey-Hyung Hwang; Young Ryun Chung; Jongheon Shin
Journal:  J Antibiot (Tokyo)       Date:  2003-10       Impact factor: 2.649

2.  Absolute configurations of macrolide antibiotics of the bafilomycin and leucanicidin groups.

Authors:  M G O'Shea; R W Rickards; J M Rothschild; E Lacey
Journal:  J Antibiot (Tokyo)       Date:  1997-12       Impact factor: 2.649

3.  Isolation and characterization of terpentecin, a new antitumor antibiotic.

Authors:  T Tamamura; T Sawa; K Isshiki; T Masuda; Y Homma; H Inuma; H Naganawa; M Hamada; T Takeuchi; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1985-12       Impact factor: 2.649

4.  Respirantin, a novel insecticidal cyclodepsipeptide from Streptomyces.

Authors:  I Urushibata; A Isogai; S Matsumoto; A Suzuki
Journal:  J Antibiot (Tokyo)       Date:  1993-04       Impact factor: 2.649

5.  Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines.

Authors:  A Monks; D Scudiero; P Skehan; R Shoemaker; K Paull; D Vistica; C Hose; J Langley; P Cronise; A Vaigro-Wolff
Journal:  J Natl Cancer Inst       Date:  1991-06-05       Impact factor: 13.506

6.  Metabolic products of microorganisms. 224. Bafilomycins, a new group of macrolide antibiotics. Production, isolation, chemical structure and biological activity.

Authors:  G Werner; H Hagenmaier; H Drautz; A Baumgartner; H Zähner
Journal:  J Antibiot (Tokyo)       Date:  1984-02       Impact factor: 2.649

7.  Total synthesis of (-)-bafilomycin A(1).

Authors:  Karl A Scheidt; Thomas D Bannister; Akihiro Tasaka; Michael D Wendt; Brad M Savall; Glenn J Fegley; William R Roush
Journal:  J Am Chem Soc       Date:  2002-06-19       Impact factor: 15.419

8.  Microbial transformation of azacarbazoles. IV. Conversion of chloro-substituted alpha-carbolines by Kitasatosporia setae strain.

Authors:  W Peczyńska-Czoch; M Mordarski; L Kaczmarek; P Nantka-Namirski
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  1987       Impact factor: 4.291

9.  Microbial transformation of azacarbazoles. VII. Antitumor properties of benzo-alpha-iso-carbolines formed by Kitasatosporia setae strain from corresponding benzo-alpha-carbolines.

Authors:  W Peczyńska-Czoch
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  1987       Impact factor: 4.291

10.  Kitasatosporia setae, an interesting actinomycete strain isolated from Spitsbergen soil.

Authors:  H Mordarska; J Wieczorek; J Zakrzewska-Czerwińska; A Zwiefka; M Mordarski
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  1987       Impact factor: 4.291

View more
  1 in total

1.  Rare Streptomyces N-formyl amino-salicylamides inhibit oncogenic K-Ras.

Authors:  Angela A Salim; Kwang-Jin Cho; Lingxiao Tan; Michelle Quezada; Ernest Lacey; John F Hancock; Robert J Capon
Journal:  Org Lett       Date:  2014-09-19       Impact factor: 6.005

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.